Cited by 54Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Diabetes and Progression of Heart Failure

Open access
Echouffo-Tcheugui, Justin B., Ndumele, Chiadi E., Zhang, Sui, Florido, Roberta, Matsushita, Kunihiro, Coresh, Josef, Skali, Hicham, Shah, Amil M. +1 more·2022·Journal of the American College of Cardiology

Abstract

Background The influence of diabetes on progression from preclinical heart failure (HF) stages to overt HF is poorly understood. Objectives The purpose of this study was to characterize the influence of diabetes on the progression from preclinical HF stages (A or B based on the 2021 Universal Definition) to overt HF. Methods We included 4,774 adults with preclinical HF (stage A [n = 1,551] or B [n = 3,223]) who attended the ARIC (Atherosclerosis Risk In Communities) study Visit 5 (2011-2013). Within each stage (A or B), we assessed the associations of diabetes and glycemic control (hemoglobin A 1C [HbA 1C] <7% vs ≥7%) with progression to HF, and of cross-categories of HF stages (A vs B), diabetes, and glycemic control with incident HF. Results Among the participants (mean age 75.4 years, 58% women, 20% Black), there were 470 HF events during 8.6 years of follow-up. Stage B participants with HbA 1C ≥7% experienced clinical HF at a younger age than those with controlled diabetes or without diabetes (mean age 80 years vs 83 years vs 82 years; P < 0.001). HbA 1C ≥7% was more strongly associated with HF in stage B (HR: 1.83; 95% CI: 1.33-2.51) compared with stage A (HR: 1.52; 95% CI: 0.53-4.38). In cross-categories of preclinical HF stage and HbA 1C, participants with stage B and HbA 1C ≥7% had increased risk of HF progression compared with stage A without diabetes (HR: 7.56; 95% CI: 4.68-12.20). Conclusions Among older adults with preclinical HF stages, uncontrolled diabetes was associated with substantial risk of HF progression. Our results suggest that targeting diabetes early in the HF process is critical.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2022.03.378

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • People with diabetes are at particularly high risk for progression from asymptomatic stage A and B to symptomatic stage C and D heart failure.

    “People with diabetes are at particularly high risk for progression from asymptomatic stage A and B to symptomatic stage C and D heart failure (219,220).”
  • People with diabetes are at particularly high risk for progression from asymptomatic stage A and B to symptomatic stage C and D heart failure.

    “People with diabetes are at particularly high risk for progression from asymptomatic stage A and B to symptomatic stage C and D heart failure (208,209).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 46 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Echouffo-Tcheugui, J. B., Ndumele, C. E., Zhang, S., Florido, R., Matsushita, K., Coresh, J., Skali, H., Shah, A. M., & Selvin, E.
Affiliations
  • Johns Hopkins University (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Echouffo-Tcheugui, Justin B.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2022-06
Volume
79
Issue
23
Pages
2285-2293
ISSN
0735-1097 (ISSN-L)
OpenAlex
W4281816045
Cited by
54
References
46
Citations by year
2026: 11 · 2025: 13 · 2024: 18 · 2023: 9 · 2022: 3
FWCI
7.49
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (HHSN268201700004I, K24HL152440, HHSN268201700001I, R01HL146907, HHSN268201700005C, HHSN268201700003I, K23HL153774, K24HL152008, HHSN268201700005I, HHSN268201700001C, R01HL143224, HHSN268201700002I, R01HL150342, HHSN268201700003C, HHSN268201700002C, HHSN268201700004C, R01HL135008, R01HL148218)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK089174)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
diabetes mellitus, heart failure progression, preclinical heart failure, glycemic control, HbA1c, incident heart failure, older adults, Atherosclerosis Risk in Communities Study
MeSH terms
Aged, Aged, 80 and over, Diabetes Mellitus, Female, Heart Failure, Glycated Hemoglobin, Humans, Male, Risk Factors, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review